Copanlisib: An Intravenous Phosphatidylinositol 3-Kinase (PI3K) Inhibitor for the Treatment of Relapsed Follicular Lymphoma.

CONCLUSIONS: Copanlisib provides an alternative option for patients with relapsed FL. It is safe and effective and has an acceptable toxicity profile.
PMID: 30813760 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - February 26, 2019 Category: Drugs & Pharmacology Authors: Eltantawy A, Vallejos X, Sebea E, Evans K Tags: Ann Pharmacother Source Type: research